The effects of modulating CRAT expression in other studies are mixed, with some demonstrating CRAT overexpression inhibits ovarian cancer growth and OXPHOS (49), whereas others found that CRAT depletion inhibits OXPHOS (48) and melanoma metastasis (61). The gene discussed is CRAT; the disease is ovarian cancer.